Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
Recruiting now
Conditions studied: Thyroid Gland Carcinoma, Thyroid Gland Nodule
In brief
This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood and tissues samples may also help researchers to differentiate non-cancerous tumors from thyroid cancer and detect high-risk mutations to guide treatment.
Key facts
- Study ID
- NCT04742608
- Run by
- Jonsson Comprehensive Cancer Center
- People needed
- 250
- Starts
- 2020-02-21
- Expected to finish
- 2027-02-01
- Last updated by the study team
- 2026-03-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged 18 and older
- Consented for thyroid surgery for thyroid cancer or indeterminate thyroid nodule
You may not qualify if…
- Patients with concurrent malignancy
Where it is running
- UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.